WILLIAM LEDFORD: Open Payments
NPI 1093759862 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 9 payments from 9 companies in 2025. Trend: 2023 $1,161 · 2024 $505 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $129 |
| Astellas Pharma US Inc | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 1 | $118 |
| Novo Nordisk Inc | 1 | $112 |
| Abbott Laboratories | 1 | $56 |
| Phathom Pharmaceuticals, Inc. | 1 | $51 |
| Otsuka America Pharmaceutical, Inc. | 1 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: KOSELUGO, Veozah, Kerendia, SPRAVATO, Wegovy, FREESTYLE LIBRE 3, VOQUEZNA, REXULTI.
Industry payments across TX — which companies pay providers there.
